1,362
Participants
Start Date
June 30, 2003
Primary Completion Date
December 31, 2005
Study Completion Date
February 28, 2007
Rosuvastatin
Beijing
Ching Qing
Guangzhou
Harbin
Jinan
Nanjing
Shanghai
Shenyang
Wuhan
New Territories
Kuching
Shah Alam
Sunway City
George Town
Kuala Lumpur
Petaling Jaya
Seberang Perai Utara
Busan
Cheonan-si
Daegu
Ilsan
Incheon
Kwangju
Pusan
Pyungchon Kyonggi
Seoul
Suwon
Wŏnju
Chunghua City
Kaohsiung City
Taichung
Taipei
Taoyuan District
Bangkok
Lead Sponsor
AstraZeneca
INDUSTRY